0001564590-18-031450.txt : 20181227 0001564590-18-031450.hdr.sgml : 20181227 20181227160819 ACCESSION NUMBER: 0001564590-18-031450 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20181227 DATE AS OF CHANGE: 20181227 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BioNano Genomics, Inc CENTRAL INDEX KEY: 0001411690 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-90660 FILM NUMBER: 181254780 BUSINESS ADDRESS: STREET 1: 9640 TOWNE CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 888-7600 MAIL ADDRESS: STREET 1: 9640 TOWNE CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BioNanomatrix Inc DATE OF NAME CHANGE: 20070906 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Wealth Strategy Holding Ltd CENTRAL INDEX KEY: 0001723544 IRS NUMBER: 000000000 STATE OF INCORPORATION: K3 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: LEVEL 12, INTERNATIONAL COMMERCE CENTRE STREET 2: 1 AUSTIN ROAD WEST CITY: HONG KONG STATE: K3 ZIP: HK BUSINESS PHONE: 36698324 MAIL ADDRESS: STREET 1: LEVEL 12, INTERNATIONAL COMMERCE CENTRE STREET 2: 1 AUSTIN ROAD WEST CITY: HONG KONG STATE: K3 ZIP: HK SC 13G 1 bngo-sc13g.htm SC 13G bngo-sc13g.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.     )*

 

Bionano Genomics, Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

09075F107

(CUSIP Number)

August 21, 2018

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

*

The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No. 09075F107

SCHEDULE 13G

Page 2 of 5

 

 

(1)

Names of reporting persons

 

WEALTH STRATEGY HOLDING LIMITED

(2)

Check the appropriate box if a member of a group (see instructions)

 

(a)  ☐        (b)  ☐

(3)

SEC use only

 

 

(4)

Citizenship or place of organization

 

HONG KONG SAR

Number of

(5)

Sole voting power

 

1,950,0001

shares

beneficially

owned by

(6)

Shared voting power

 

 

each

reporting

person

(7)

Sole dispositive power

 

1,950,0001

with:

(8)

Shared dispositive power

 

 

(9)

Aggregate amount beneficially owned by each reporting person

 

1,950,000

(10)

Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

 

☐

(11)

Percent of class represented by amount in Row (9)

 

15.13%

(12)

Type of reporting person (see instructions)

 

FI

 

 

1 By virtue of being the controlling shareholder and/ / or director of the Reporting Person, Mr. Kung Hung Ka may be deemed to have sole voting and dispositive power with respect to these shares.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CUSIP No. 09075F107

SCHEDULE 13G

Page 3 of 5

 

Item 1.

 

(a)Name of Issuer:

Bionano Genomics, Inc

 

(b)

Address of Issuer's Principal Executive Offices:

9540 Towne Centre Drive, Suite 100

San Diego, California 92121

 

Item 2.

 

(a)

Name of Person Filing:

WEALTH STRATEGY HOLDING LIMITED

 

(b)Address of Principal Business Office or, if none, Residence:

WEALTH STRATEGY HOLDING LIMITED

Level 12,

International Commerce Centre,

1 Austin Road West,

Kowloon, Hong Kong

 

(c)Citizenship:

Hong Kong

 

(d)Title of Class of Securities:

Common Stock

 

(e)CUSIP Number:

09075F107

 

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or §§ 240.13d-2(b) or (c), check whether the person filing is a:

Not Applicable

 

 

Item 4.

Ownership:

 

 

(a)

Amount beneficially owned:

975,000 shares, including warrants to acquire 975,000 shares

 

 

(b)

Percent of class:

15.13%

 

(c)Number of shares as to which such person has:

 

(i)Sole power to vote or to direct the vote: 1,950,000

(ii)Shared power to vote or to direct the vote:

(iii)Sole power to dispose or to direct the disposition of: 1,950,000

(iv)Shared power to dispose or to direct the disposition of:

 

 

 

CUSIP No. 09075F107

SCHEDULE 13G

Page 4 of 5

 

 

Item 5.

Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [   ].

  

Item 6.

Ownership of More than Five Percent on Behalf of Another Person:

Not Applicable

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Not Applicable

 

Item 8.

Identification and Classification of Members of the Group:

Not Applicable

 

Item 9.

Notice of Dissolution of Group:

Not Applicable

 

Item 10.

Certifications:

Not Applicable

 


 

CUSIP No. 09075F107

SCHEDULE 13G

Page 5 of 5

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

                 December 14, 2018

Date

 

 

/s/ Ken Tsang

Ken Tsang

 

Title: Compliance Officer